Raphael Pharmaceutical Inc. Cash and Cash Equivalents
Raphael Pharmaceutical Inc. (RAPH) had Cash and Cash Equivalents of $20.00 thousand as of 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2025-08-13
- 2025-06-30: Cash and Cash Equivalents, at Carrying Value $20.00K.
- 2025-03-31: Cash and Cash Equivalents, at Carrying Value $50.00K.
- 2024-12-31: Cash and Cash Equivalents, at Carrying Value $19.00K.
- 2024-09-30: Cash and Cash Equivalents, at Carrying Value $40.00K.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2025-06-30 | $20.00K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $50.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $19.00K 10-Q · filed 2025-08-13 |
| 2024-09-30 | $40.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $120.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $287.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $230.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $299.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $111.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $38.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $288.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $93.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $135.00K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $81.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $153.00K 10-K/A · filed 2023-05-25 |
| 2021-09-30 | $37.00K 10-Q · filed 2021-11-16 |
| 2020-12-31 | $95.00K 10-K · filed 2022-03-30 |
| 2020-09-30 | $36.00K 10-Q · filed 2021-11-16 |
| 2019-12-31 | $50.00K 10-Q · filed 2021-11-16 |